Concepts (405)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carotenoids | 38 | 2024 | 80 | 10.720 |
Why?
|
| Bees | 24 | 2024 | 53 | 9.190 |
Why?
|
| Symbiosis | 26 | 2024 | 102 | 7.520 |
Why?
|
| Diet | 20 | 2024 | 1195 | 3.380 |
Why?
|
| Gastrointestinal Microbiome | 14 | 2024 | 822 | 3.240 |
Why?
|
| Hemiptera | 8 | 2022 | 19 | 2.820 |
Why?
|
| Gammaproteobacteria | 7 | 2022 | 23 | 2.730 |
Why?
|
| Bacteria | 17 | 2025 | 537 | 2.630 |
Why?
|
| Vegetables | 9 | 2024 | 276 | 2.520 |
Why?
|
| Gastrointestinal Tract | 13 | 2017 | 243 | 2.500 |
Why?
|
| Aphids | 7 | 2023 | 14 | 2.390 |
Why?
|
| Buchnera | 6 | 2021 | 6 | 2.130 |
Why?
|
| Fruit | 12 | 2024 | 238 | 2.120 |
Why?
|
| Genome, Bacterial | 10 | 2025 | 212 | 2.080 |
Why?
|
| beta Carotene | 6 | 2024 | 41 | 2.030 |
Why?
|
| Skin | 5 | 2024 | 545 | 1.790 |
Why?
|
| Phylogeny | 13 | 2025 | 785 | 1.720 |
Why?
|
| Neisseriaceae | 4 | 2020 | 5 | 1.680 |
Why?
|
| Prostatic Neoplasms | 9 | 2024 | 1626 | 1.610 |
Why?
|
| Type VI Secretion Systems | 2 | 2024 | 3 | 1.490 |
Why?
|
| Milk, Human | 3 | 2024 | 311 | 1.470 |
Why?
|
| Intestinal Absorption | 3 | 2017 | 193 | 1.450 |
Why?
|
| Spectrum Analysis | 5 | 2024 | 69 | 1.360 |
Why?
|
| Animals | 61 | 2025 | 36557 | 1.330 |
Why?
|
| Evolution, Molecular | 8 | 2025 | 710 | 1.320 |
Why?
|
| Insecta | 3 | 2015 | 67 | 1.260 |
Why?
|
| Biomarkers | 7 | 2024 | 3434 | 1.030 |
Why?
|
| Dioxygenases | 3 | 2022 | 65 | 0.970 |
Why?
|
| Anticarcinogenic Agents | 3 | 2022 | 54 | 0.910 |
Why?
|
| beta-Carotene 15,15'-Monooxygenase | 4 | 2024 | 4 | 0.910 |
Why?
|
| Honey | 1 | 2023 | 4 | 0.840 |
Why?
|
| Milk | 1 | 2024 | 123 | 0.830 |
Why?
|
| Urticaria | 1 | 2023 | 21 | 0.820 |
Why?
|
| Metagenome | 3 | 2014 | 158 | 0.820 |
Why?
|
| Nutrition Assessment | 1 | 2024 | 138 | 0.820 |
Why?
|
| Parasites | 1 | 2023 | 38 | 0.800 |
Why?
|
| Antioxidants | 2 | 2015 | 378 | 0.790 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2023 | 31 | 0.790 |
Why?
|
| Soybean Proteins | 2 | 2019 | 17 | 0.770 |
Why?
|
| Microbiota | 6 | 2023 | 443 | 0.760 |
Why?
|
| Host Specificity | 3 | 2017 | 23 | 0.720 |
Why?
|
| Bacterial Physiological Phenomena | 5 | 2018 | 21 | 0.710 |
Why?
|
| Varroidae | 1 | 2020 | 1 | 0.670 |
Why?
|
| Molecular Sequence Data | 12 | 2014 | 3980 | 0.660 |
Why?
|
| Biodiversity | 4 | 2018 | 89 | 0.650 |
Why?
|
| Databases, Factual | 1 | 2024 | 1258 | 0.620 |
Why?
|
| Neonicotinoids | 1 | 2018 | 2 | 0.600 |
Why?
|
| Nitro Compounds | 1 | 2018 | 19 | 0.590 |
Why?
|
| Antibiosis | 1 | 2017 | 14 | 0.570 |
Why?
|
| Gene Expression Regulation, Bacterial | 2 | 2012 | 173 | 0.540 |
Why?
|
| Vitamins | 1 | 2017 | 113 | 0.530 |
Why?
|
| Biological Evolution | 4 | 2022 | 256 | 0.530 |
Why?
|
| Enterobacteriaceae | 2 | 2014 | 41 | 0.530 |
Why?
|
| Bacterial Toxins | 1 | 2017 | 177 | 0.520 |
Why?
|
| Biological Availability | 5 | 2018 | 153 | 0.510 |
Why?
|
| Dietary Fats | 1 | 2017 | 300 | 0.490 |
Why?
|
| DNA, Bacterial | 6 | 2015 | 499 | 0.480 |
Why?
|
| Prostate | 6 | 2024 | 449 | 0.480 |
Why?
|
| RNA, Ribosomal, 16S | 7 | 2023 | 406 | 0.480 |
Why?
|
| Carcinogenesis | 5 | 2023 | 364 | 0.480 |
Why?
|
| Lutein | 3 | 2023 | 15 | 0.460 |
Why?
|
| Cancer Survivors | 1 | 2018 | 249 | 0.460 |
Why?
|
| Dietary Supplements | 2 | 2015 | 489 | 0.460 |
Why?
|
| Health Promotion | 1 | 2018 | 405 | 0.460 |
Why?
|
| Genomics | 4 | 2025 | 1681 | 0.450 |
Why?
|
| Genotype | 4 | 2024 | 2814 | 0.440 |
Why?
|
| Male | 34 | 2024 | 66127 | 0.440 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2024 | 2947 | 0.430 |
Why?
|
| Cognitive Dysfunction | 1 | 2018 | 314 | 0.430 |
Why?
|
| Carbon Isotopes | 5 | 2015 | 279 | 0.420 |
Why?
|
| Zeaxanthins | 2 | 2023 | 10 | 0.410 |
Why?
|
| Sequence Analysis, DNA | 6 | 2014 | 1837 | 0.410 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 196 | 0.410 |
Why?
|
| Tetracycline Resistance | 1 | 2012 | 8 | 0.400 |
Why?
|
| Halomonadaceae | 1 | 2012 | 1 | 0.400 |
Why?
|
| Biota | 1 | 2012 | 8 | 0.400 |
Why?
|
| Vitamin A | 3 | 2023 | 62 | 0.400 |
Why?
|
| Tetracyclines | 1 | 2012 | 22 | 0.390 |
Why?
|
| RNA 3' End Processing | 1 | 2012 | 7 | 0.390 |
Why?
|
| Humans | 40 | 2024 | 134156 | 0.380 |
Why?
|
| RNA, Transfer | 1 | 2012 | 77 | 0.380 |
Why?
|
| Tissue Distribution | 5 | 2015 | 402 | 0.370 |
Why?
|
| Models, Biological | 2 | 2015 | 1539 | 0.360 |
Why?
|
| Isotope Labeling | 4 | 2013 | 106 | 0.360 |
Why?
|
| Fabaceae | 2 | 2001 | 27 | 0.350 |
Why?
|
| Amino Acids, Essential | 1 | 2011 | 28 | 0.350 |
Why?
|
| Reproducibility of Results | 4 | 2024 | 3043 | 0.350 |
Why?
|
| Potassium Channels | 2 | 2001 | 166 | 0.320 |
Why?
|
| Transcriptome | 1 | 2016 | 1138 | 0.320 |
Why?
|
| Infant | 6 | 2024 | 13240 | 0.310 |
Why?
|
| Self Report | 2 | 2024 | 553 | 0.300 |
Why?
|
| Reproduction | 2 | 2023 | 245 | 0.290 |
Why?
|
| Beverages | 2 | 2019 | 102 | 0.290 |
Why?
|
| Liver | 5 | 2024 | 1879 | 0.290 |
Why?
|
| Species Specificity | 4 | 2025 | 571 | 0.290 |
Why?
|
| Glucose | 1 | 2013 | 927 | 0.290 |
Why?
|
| Female | 21 | 2024 | 71928 | 0.290 |
Why?
|
| Adaptation, Biological | 2 | 2020 | 36 | 0.290 |
Why?
|
| Intestines | 1 | 2012 | 614 | 0.280 |
Why?
|
| Genome, Insect | 2 | 2020 | 116 | 0.280 |
Why?
|
| Genetic Variation | 3 | 2025 | 1631 | 0.280 |
Why?
|
| Cross-Sectional Studies | 6 | 2024 | 3754 | 0.270 |
Why?
|
| Intracranial Embolism | 2 | 2019 | 30 | 0.270 |
Why?
|
| Middle Aged | 13 | 2024 | 29399 | 0.260 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2017 | 964 | 0.260 |
Why?
|
| Escherichia coli | 3 | 2017 | 1027 | 0.250 |
Why?
|
| Fatty Acids | 3 | 2013 | 372 | 0.250 |
Why?
|
| Mutagenesis | 2 | 2017 | 357 | 0.250 |
Why?
|
| Adult | 13 | 2024 | 31945 | 0.250 |
Why?
|
| Carotid Stenosis | 2 | 2019 | 135 | 0.250 |
Why?
|
| Half-Life | 2 | 2015 | 162 | 0.240 |
Why?
|
| Gene Expression Regulation | 2 | 2014 | 2669 | 0.240 |
Why?
|
| Calcium | 2 | 2001 | 1148 | 0.240 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 2771 | 0.240 |
Why?
|
| Eukaryota | 1 | 2025 | 25 | 0.230 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2024 | 39 | 0.230 |
Why?
|
| Fruit and Vegetable Juices | 1 | 2024 | 5 | 0.220 |
Why?
|
| Diet Records | 1 | 2024 | 76 | 0.220 |
Why?
|
| Parthenogenesis | 1 | 2023 | 3 | 0.220 |
Why?
|
| Alkaloids | 1 | 2024 | 37 | 0.210 |
Why?
|
| Betaproteobacteria | 2 | 2014 | 2 | 0.210 |
Why?
|
| Biofilms | 2 | 2016 | 99 | 0.210 |
Why?
|
| Cytosol | 2 | 2001 | 169 | 0.210 |
Why?
|
| Bacteroidetes | 2 | 2014 | 23 | 0.210 |
Why?
|
| Kinetics | 2 | 2015 | 1357 | 0.210 |
Why?
|
| Agriculture | 1 | 2023 | 34 | 0.210 |
Why?
|
| Genes, Essential | 1 | 2023 | 43 | 0.200 |
Why?
|
| RNA, Double-Stranded | 1 | 2023 | 67 | 0.200 |
Why?
|
| Base Composition | 2 | 2013 | 75 | 0.200 |
Why?
|
| Base Sequence | 4 | 2012 | 3180 | 0.200 |
Why?
|
| Ecosystem | 2 | 2014 | 110 | 0.200 |
Why?
|
| Ubiquinone | 2 | 2013 | 29 | 0.200 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2024 | 198 | 0.200 |
Why?
|
| X Chromosome | 1 | 2023 | 342 | 0.200 |
Why?
|
| Bacterial Typing Techniques | 2 | 2013 | 104 | 0.200 |
Why?
|
| Infant Formula | 1 | 2023 | 100 | 0.200 |
Why?
|
| Oxygenases | 1 | 2022 | 4 | 0.190 |
Why?
|
| Polyploidy | 1 | 2022 | 19 | 0.190 |
Why?
|
| Organelles | 1 | 2022 | 23 | 0.190 |
Why?
|
| Hospitalization | 2 | 2024 | 1906 | 0.190 |
Why?
|
| Pulvinus | 1 | 2001 | 1 | 0.190 |
Why?
|
| Work Performance | 1 | 2022 | 14 | 0.190 |
Why?
|
| Mice | 9 | 2024 | 19055 | 0.190 |
Why?
|
| Genome | 1 | 2025 | 528 | 0.190 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2001 | 39 | 0.180 |
Why?
|
| Food | 2 | 2022 | 140 | 0.180 |
Why?
|
| Basal Bodies | 1 | 2021 | 2 | 0.180 |
Why?
|
| Testosterone | 3 | 2023 | 623 | 0.180 |
Why?
|
| Diet Surveys | 2 | 2020 | 103 | 0.180 |
Why?
|
| Gene Expression Profiling | 5 | 2024 | 1923 | 0.180 |
Why?
|
| Ataxia | 1 | 2022 | 177 | 0.180 |
Why?
|
| Trees | 1 | 2000 | 21 | 0.170 |
Why?
|
| Coinfection | 1 | 2022 | 184 | 0.170 |
Why?
|
| Potassium | 1 | 2001 | 290 | 0.170 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 2578 | 0.170 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2011 | 95 | 0.170 |
Why?
|
| Parenting | 2 | 2021 | 348 | 0.170 |
Why?
|
| Young Adult | 4 | 2024 | 9944 | 0.170 |
Why?
|
| Parents | 3 | 2023 | 1071 | 0.170 |
Why?
|
| Cooking | 1 | 2020 | 38 | 0.160 |
Why?
|
| Swine | 1 | 2023 | 1219 | 0.160 |
Why?
|
| Aged | 8 | 2024 | 21775 | 0.160 |
Why?
|
| Meals | 1 | 2020 | 61 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 1218 | 0.160 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2019 | 286 | 0.160 |
Why?
|
| Carbon Radioisotopes | 1 | 2009 | 75 | 0.160 |
Why?
|
| Disease Susceptibility | 2 | 2018 | 320 | 0.160 |
Why?
|
| Herbicides | 1 | 2009 | 14 | 0.160 |
Why?
|
| Phytochemicals | 1 | 2019 | 10 | 0.150 |
Why?
|
| Genetic Engineering | 1 | 2020 | 164 | 0.150 |
Why?
|
| Serratia | 1 | 2018 | 1 | 0.150 |
Why?
|
| Serratia Infections | 1 | 2018 | 6 | 0.150 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2018 | 33 | 0.150 |
Why?
|
| Texas | 2 | 2024 | 3716 | 0.150 |
Why?
|
| Proteomics | 1 | 2022 | 599 | 0.140 |
Why?
|
| Life Style | 1 | 2021 | 463 | 0.140 |
Why?
|
| Pesticides | 1 | 2018 | 31 | 0.140 |
Why?
|
| Linkage Disequilibrium | 1 | 2019 | 333 | 0.140 |
Why?
|
| Aspirin | 1 | 2019 | 231 | 0.140 |
Why?
|
| RNA Interference | 1 | 2020 | 548 | 0.140 |
Why?
|
| Infant, Premature | 1 | 2023 | 858 | 0.140 |
Why?
|
| Plant Extracts | 2 | 2015 | 138 | 0.140 |
Why?
|
| Amino Acid Sequence | 3 | 2012 | 2795 | 0.140 |
Why?
|
| Gene Expression | 2 | 2022 | 1621 | 0.140 |
Why?
|
| Androgens | 2 | 2023 | 300 | 0.140 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 1761 | 0.140 |
Why?
|
| Feeding Behavior | 2 | 2021 | 732 | 0.140 |
Why?
|
| Environment | 1 | 2018 | 156 | 0.140 |
Why?
|
| Disease Models, Animal | 2 | 2022 | 4808 | 0.140 |
Why?
|
| Seizures | 1 | 2022 | 890 | 0.140 |
Why?
|
| Exercise | 1 | 2023 | 869 | 0.140 |
Why?
|
| Alphaproteobacteria | 1 | 2016 | 3 | 0.130 |
Why?
|
| Cluster Analysis | 2 | 2016 | 440 | 0.130 |
Why?
|
| Ants | 1 | 2016 | 9 | 0.130 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2013 | 363 | 0.130 |
Why?
|
| Gerbillinae | 2 | 2013 | 55 | 0.130 |
Why?
|
| Blood Platelets | 1 | 2019 | 342 | 0.130 |
Why?
|
| Multigene Family | 1 | 2017 | 324 | 0.130 |
Why?
|
| Models, Animal | 1 | 2018 | 486 | 0.130 |
Why?
|
| Patch-Clamp Techniques | 3 | 2001 | 300 | 0.130 |
Why?
|
| Influenza, Human | 1 | 2022 | 699 | 0.130 |
Why?
|
| Glutamate-Ammonia Ligase | 2 | 2016 | 13 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2023 | 951 | 0.120 |
Why?
|
| Colectomy | 1 | 2016 | 84 | 0.120 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2016 | 141 | 0.120 |
Why?
|
| Stereoisomerism | 1 | 2015 | 119 | 0.120 |
Why?
|
| Nutritive Value | 1 | 2015 | 93 | 0.120 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2014 | 548 | 0.120 |
Why?
|
| Adolescent | 5 | 2024 | 20624 | 0.120 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 920 | 0.120 |
Why?
|
| Up-Regulation | 1 | 2017 | 915 | 0.110 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2014 | 21 | 0.110 |
Why?
|
| Scavenger Receptors, Class B | 2 | 2024 | 12 | 0.110 |
Why?
|
| DNA, Ribosomal | 1 | 2014 | 57 | 0.110 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2014 | 51 | 0.110 |
Why?
|
| Prospective Studies | 2 | 2023 | 6601 | 0.110 |
Why?
|
| Thrombin | 1 | 2014 | 63 | 0.110 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2014 | 295 | 0.110 |
Why?
|
| Genes, Insect | 1 | 2014 | 126 | 0.110 |
Why?
|
| Chronic Disease | 1 | 2018 | 1250 | 0.110 |
Why?
|
| Intestinal Mucosa | 2 | 2024 | 816 | 0.110 |
Why?
|
| Colitis, Ulcerative | 1 | 2016 | 218 | 0.100 |
Why?
|
| Receptors, Androgen | 1 | 2016 | 433 | 0.100 |
Why?
|
| Flavobacteriaceae | 1 | 2013 | 4 | 0.100 |
Why?
|
| Seminiferous Tubules | 1 | 2012 | 15 | 0.100 |
Why?
|
| Survival Rate | 1 | 2018 | 2218 | 0.100 |
Why?
|
| Drosophila | 1 | 2017 | 829 | 0.100 |
Why?
|
| Safflower Oil | 1 | 2012 | 1 | 0.100 |
Why?
|
| Arizona | 1 | 2012 | 27 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 2 | 2015 | 1627 | 0.100 |
Why?
|
| Polygalacturonase | 1 | 2012 | 3 | 0.100 |
Why?
|
| Child | 5 | 2024 | 25890 | 0.100 |
Why?
|
| Pectins | 1 | 2012 | 9 | 0.100 |
Why?
|
| RNA Editing | 1 | 2012 | 36 | 0.100 |
Why?
|
| Codon | 1 | 2012 | 109 | 0.100 |
Why?
|
| Plant Oils | 1 | 2012 | 37 | 0.100 |
Why?
|
| Carbohydrate Metabolism | 1 | 2012 | 58 | 0.100 |
Why?
|
| Cytokines | 1 | 2018 | 1401 | 0.100 |
Why?
|
| Body Mass Index | 1 | 2018 | 1719 | 0.090 |
Why?
|
| Genes, Bacterial | 1 | 2012 | 218 | 0.090 |
Why?
|
| Fatty Liver | 1 | 2014 | 215 | 0.090 |
Why?
|
| Selection, Genetic | 1 | 2012 | 169 | 0.090 |
Why?
|
| Nucleic Acid Conformation | 1 | 2012 | 198 | 0.090 |
Why?
|
| Pilot Projects | 3 | 2021 | 1493 | 0.090 |
Why?
|
| Diet, Protein-Restricted | 1 | 2012 | 82 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2013 | 3188 | 0.090 |
Why?
|
| Metagenomics | 1 | 2012 | 110 | 0.090 |
Why?
|
| Glutamate Synthase | 1 | 2011 | 1 | 0.090 |
Why?
|
| Fetal Development | 1 | 2012 | 135 | 0.090 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2011 | 35 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2018 | 3668 | 0.090 |
Why?
|
| Weight Gain | 1 | 2013 | 413 | 0.090 |
Why?
|
| Inflammation | 1 | 2018 | 1595 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2014 | 1071 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2023 | 8623 | 0.080 |
Why?
|
| Adipose Tissue | 1 | 2013 | 510 | 0.080 |
Why?
|
| Protein Biosynthesis | 2 | 2012 | 678 | 0.080 |
Why?
|
| Chromosome Mapping | 1 | 2012 | 1126 | 0.080 |
Why?
|
| Models, Genetic | 1 | 2012 | 789 | 0.080 |
Why?
|
| Organ Size | 3 | 2016 | 467 | 0.070 |
Why?
|
| Sequence Analysis, RNA | 1 | 2011 | 426 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 4 | 2024 | 4879 | 0.070 |
Why?
|
| United States | 3 | 2024 | 11763 | 0.070 |
Why?
|
| Mice, Transgenic | 3 | 2023 | 2539 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 1071 | 0.070 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 2 | 2019 | 119 | 0.070 |
Why?
|
| Feasibility Studies | 2 | 2021 | 827 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 2137 | 0.060 |
Why?
|
| Child, Preschool | 4 | 2023 | 14884 | 0.060 |
Why?
|
| Gene Flow | 1 | 2025 | 15 | 0.060 |
Why?
|
| Bacterial Proteins | 2 | 2016 | 934 | 0.060 |
Why?
|
| Caco-2 Cells | 1 | 2024 | 97 | 0.060 |
Why?
|
| Hemoglobins | 2 | 2023 | 322 | 0.050 |
Why?
|
| CD36 Antigens | 1 | 2024 | 42 | 0.050 |
Why?
|
| Xenobiotics | 1 | 2024 | 29 | 0.050 |
Why?
|
| Ecology | 1 | 2023 | 16 | 0.050 |
Why?
|
| Melanins | 1 | 2023 | 20 | 0.050 |
Why?
|
| Accelerometry | 1 | 2023 | 64 | 0.050 |
Why?
|
| Heat-Shock Response | 1 | 2003 | 36 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2016 | 4016 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2016 | 720 | 0.050 |
Why?
|
| Steroids | 1 | 2024 | 213 | 0.050 |
Why?
|
| Mammals | 1 | 2024 | 282 | 0.050 |
Why?
|
| Tetraethylammonium | 1 | 2001 | 11 | 0.050 |
Why?
|
| Death | 1 | 2022 | 80 | 0.050 |
Why?
|
| Cesium | 1 | 2001 | 15 | 0.050 |
Why?
|
| Geranylgeranyl-Diphosphate Geranylgeranyltransferase | 1 | 2011 | 2 | 0.050 |
Why?
|
| Extracellular Space | 1 | 2001 | 89 | 0.050 |
Why?
|
| Enterobacter | 1 | 2011 | 15 | 0.050 |
Why?
|
| Alkyl and Aryl Transferases | 1 | 2011 | 19 | 0.050 |
Why?
|
| Bioengineering | 1 | 2011 | 15 | 0.050 |
Why?
|
| Membranes | 1 | 2021 | 24 | 0.050 |
Why?
|
| Flagella | 1 | 2021 | 29 | 0.050 |
Why?
|
| Gene Rearrangement | 1 | 2003 | 331 | 0.040 |
Why?
|
| Protons | 1 | 2001 | 98 | 0.040 |
Why?
|
| Proteome | 1 | 2003 | 281 | 0.040 |
Why?
|
| Oxidoreductases | 1 | 2011 | 103 | 0.040 |
Why?
|
| Electrophysiology | 1 | 2001 | 281 | 0.040 |
Why?
|
| Seasons | 1 | 2022 | 334 | 0.040 |
Why?
|
| DNA, Plant | 1 | 2000 | 12 | 0.040 |
Why?
|
| Biological Transport | 1 | 2001 | 371 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2001 | 470 | 0.040 |
Why?
|
| Introduced Species | 1 | 2020 | 27 | 0.040 |
Why?
|
| Vitis | 1 | 2020 | 16 | 0.040 |
Why?
|
| Animal Distribution | 1 | 2020 | 16 | 0.040 |
Why?
|
| Plant Leaves | 1 | 2000 | 54 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2023 | 481 | 0.040 |
Why?
|
| Testis | 2 | 2012 | 433 | 0.040 |
Why?
|
| Ion Channel Gating | 1 | 2000 | 126 | 0.040 |
Why?
|
| Metabolomics | 1 | 2024 | 470 | 0.040 |
Why?
|
| Prenatal Care | 1 | 2022 | 359 | 0.040 |
Why?
|
| Membrane Potentials | 1 | 2001 | 318 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2021 | 370 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2001 | 489 | 0.040 |
Why?
|
| Parent-Child Relations | 1 | 2021 | 254 | 0.040 |
Why?
|
| Movement | 1 | 2000 | 166 | 0.040 |
Why?
|
| Nutritional Status | 1 | 2021 | 325 | 0.040 |
Why?
|
| Hydroxides | 1 | 2008 | 3 | 0.040 |
Why?
|
| Potassium Compounds | 1 | 2008 | 8 | 0.040 |
Why?
|
| Faculty, Medical | 1 | 2022 | 279 | 0.040 |
Why?
|
| Middle Cerebral Artery | 1 | 2019 | 118 | 0.040 |
Why?
|
| Organophosphates | 1 | 2008 | 21 | 0.040 |
Why?
|
| North Carolina | 1 | 2018 | 66 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 1440 | 0.040 |
Why?
|
| Statistics as Topic | 1 | 2008 | 261 | 0.030 |
Why?
|
| Ferritins | 1 | 1997 | 109 | 0.030 |
Why?
|
| Type I Secretion Systems | 1 | 2016 | 1 | 0.030 |
Why?
|
| Nitrogen Fixation | 1 | 2016 | 5 | 0.030 |
Why?
|
| Choristoma | 1 | 1997 | 50 | 0.030 |
Why?
|
| Ethanol | 1 | 2008 | 170 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2008 | 294 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2019 | 278 | 0.030 |
Why?
|
| Urease | 1 | 2016 | 74 | 0.030 |
Why?
|
| Erythrocytes | 1 | 1997 | 238 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 3798 | 0.030 |
Why?
|
| Pollination | 1 | 2016 | 1 | 0.030 |
Why?
|
| Temporal Lobe | 1 | 1997 | 118 | 0.030 |
Why?
|
| Infliximab | 1 | 2016 | 68 | 0.030 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 1997 | 91 | 0.030 |
Why?
|
| Australia | 1 | 2016 | 186 | 0.030 |
Why?
|
| Prevalence | 1 | 2022 | 2684 | 0.030 |
Why?
|
| Cyclosporine | 1 | 2016 | 148 | 0.030 |
Why?
|
| Plant Preparations | 1 | 2015 | 17 | 0.030 |
Why?
|
| Pregnancy | 2 | 2022 | 7570 | 0.030 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2016 | 142 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2014 | 1107 | 0.030 |
Why?
|
| Cell Line | 1 | 2010 | 2864 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 7217 | 0.030 |
Why?
|
| Plasma | 1 | 2015 | 105 | 0.030 |
Why?
|
| China | 1 | 2015 | 296 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2014 | 258 | 0.030 |
Why?
|
| Brain Diseases | 1 | 1997 | 310 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 1190 | 0.030 |
Why?
|
| Prostatectomy | 1 | 2015 | 357 | 0.030 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2014 | 76 | 0.030 |
Why?
|
| Venous Thromboembolism | 1 | 2016 | 185 | 0.030 |
Why?
|
| Random Allocation | 1 | 2014 | 449 | 0.030 |
Why?
|
| Coconut Oil | 1 | 2012 | 2 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2016 | 4934 | 0.020 |
Why?
|
| Consensus | 1 | 2016 | 732 | 0.020 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2012 | 51 | 0.020 |
Why?
|
| Cytochrome P-450 CYP11B2 | 1 | 2011 | 7 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 1332 | 0.020 |
Why?
|
| Spleen | 1 | 2012 | 292 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2012 | 398 | 0.020 |
Why?
|
| Stroke | 1 | 2019 | 1077 | 0.020 |
Why?
|
| Lactation | 1 | 2012 | 200 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 3999 | 0.020 |
Why?
|
| Triglycerides | 1 | 2014 | 617 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 396 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 1997 | 891 | 0.020 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2012 | 243 | 0.020 |
Why?
|
| Amino Acids | 1 | 2013 | 688 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 1991 | 256 | 0.020 |
Why?
|
| Cholesterol | 1 | 2012 | 575 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 2563 | 0.020 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2014 | 429 | 0.020 |
Why?
|
| Body Weight | 1 | 2012 | 1041 | 0.020 |
Why?
|
| DNA | 1 | 2014 | 1682 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2014 | 2915 | 0.020 |
Why?
|
| Time Factors | 1 | 2018 | 6610 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2013 | 877 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2014 | 1721 | 0.020 |
Why?
|
| Glioma | 1 | 1991 | 540 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 11182 | 0.010 |
Why?
|
| Anemia, Hypochromic | 1 | 1997 | 7 | 0.010 |
Why?
|
| Aluminum | 1 | 1997 | 12 | 0.010 |
Why?
|
| Vitamin B 12 | 1 | 1997 | 63 | 0.010 |
Why?
|
| Gliosis | 1 | 1997 | 33 | 0.010 |
Why?
|
| Erythropoietin | 1 | 1997 | 111 | 0.010 |
Why?
|
| Amygdala | 1 | 1997 | 87 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1997 | 727 | 0.010 |
Why?
|
| Folic Acid | 1 | 1997 | 298 | 0.010 |
Why?
|
| Iron | 1 | 1997 | 305 | 0.010 |
Why?
|
| Hippocampus | 1 | 1997 | 863 | 0.010 |
Why?
|
| RNA Probes | 1 | 1991 | 31 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1991 | 272 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1991 | 311 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1991 | 361 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1991 | 993 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1991 | 746 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1997 | 5477 | 0.000 |
Why?
|
| Rats | 1 | 1991 | 3890 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 1997 | 13074 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 1991 | 1787 | 0.000 |
Why?
|